Table 1.

Correlation of HERV-K-T47D-RT Expression to Clinicopathologic Characteristics.

Variable	HERV-K-T47D-RT*		P†
	-	+
Stage
1	30 (39%)	8 (30%)	.36
2	46 (61%)	19 (70%)
Unknown	5	2
Total	81	29
Age (yr)
<55	34 (45%)	6 (22%)	.04
56–80	42 (55%)	21 (78%)
Unknown	5	2
Total	81	29
Death
Yes	20 (25%)	12 (41%)	.09
No	61 (75%)	17 (59%)
Total	81	29
LR
Yes	44 (54%)	15 (52%)	.8
No	37 (46%)	14 (48%)
Total	81	29
DM
Yes	16 (20%)	11 (38%)	.05
No	65 (80%)	18 (62%)
Total	81	29
ER
Yes	51 (63%)	17 (59%)	.68
No	30 (37%)	12 (41%)
Total	81	29
PGR
Yes	44 (54%)	15 (52%)	.81
No	37 (46%)	14 (48%)
Total	81	29
Menopausal
Post	17 (23%)	8 (28%)	.6
Pre	58 (77%)	21 (72%)
Unknown	6
Total	81	29

DM indicates distal metastasis; ER, estrogen receptor; LR, local recurrence; PGR, progesterone receptor.

^*For consistency with our rating system, HERV-K-T47D-RT-positive expression was an AAI value above the cutoff of 1.2.

^†χ² test.